[EVALI: Severe ARDS requiring ECMO due to e-cigarette use in a 16-year-old male patient]

EVALI, or e-cigarette or vaping product use-associated lung injury, has emerged as a serious health concern linked to vaping. This report highlights a case involving a 16-year-old male who developed severe Acute Respiratory Distress Syndrome (ARDS) requiring advanced life support with ECMO.

The case underscores the potential life-threatening consequences of e-cigarette use, especially among adolescents. It emphasizes the importance of awareness, prevention, and regulation to protect youth from vaping-related health risks.

This case illustrates the severe health risks associated with e-cigarette use, especially among young people. Understanding these dangers can help inform public health strategies and policies aimed at reducing vaping among youth.

Highlighting such cases raises awareness about the potential for life-threatening complications, encouraging safer behaviors and stricter regulation of vaping products.

Vaping-related lung injuries pose a significant public health challenge, particularly for adolescents. Recognizing and addressing these risks is essential to prevent severe health outcomes and protect youth health.

Public health initiatives must focus on education, regulation, and cessation support to combat the rising trend of vaping-related illnesses.

This case underscores the need for stronger policies regulating e-cigarette sales and marketing to minors. Implementing stricter controls can help reduce youth access and prevent severe health consequences.

Policymakers should consider evidence-based strategies to limit vaping among adolescents and promote safer alternatives for nicotine consumption.